CrushSCI.com
120.5平均天数
128中位天数
69最短天数
178最长天数
1842025发文量

Paper Review Records

全部论文审稿周期

21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

69 天

Four decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)– Part I: Product Quality

作者
Mehul Mehta展开收起
作者单位
1. Division of Neuropsychiatric Products, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, USA展开收起
PDF源文件 DOI 网页
78 天

Four Decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)—Part II: Dose Individualization and Approvability Evidence

作者
Mehul Mehta展开收起
作者单位
1. Division of Neuropsychiatric Products, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, USA展开收起
PDF源文件 DOI 网页
131 天

Engineering and Characterisation of 3D-Printed Timolol Maleate Implants for Long-Acting Glaucoma Treatment

作者
Febri Annuryanti; Masoud Adhami; Eneko Larrañeta; Lalitkumar Vora; Thakur Raghu Raj Singh展开收起
作者单位
1. Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia; 2. McClay Research Centre, Medical Biology Centre, School of Pharmacy, Queen’s University Belfast, Belfast, UK展开收起
PDF源文件 DOI 网页
74 天

Verification of a Physiologically-based Pharmacokinetic Model for Predicting CYP3A4-mediated Simvastatin and Simvastatin Acid Drug-drug Interactions

作者
Bridget L. Morse; Bing Han; Jeffrey J. Alberts; Maria M. Posada; Gemma L. Dickinson; Stephen D. Hall展开收起
作者单位
1. Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, USA; 2. Clinical & Quantitative Pharmacology, Vertex Pharmaceuticals, Boston, USA展开收起
PDF源文件 DOI 网页
118 天

Exploring a Persistent Terbinafine – CYP2D6 Interaction Using Physiologically – Based Pharmacokinetic Modeling

作者
Devendra Pade; Jan Wahlstrom展开收起
作者单位
1. Pharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, USA; 2. Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, USA展开收起
PDF源文件 DOI 网页
128 天

Immunogenicity Assays Used in Support of Marketing Applications of Oligonucleotide Therapeutics

作者
Cecilia Arfvidsson; Lin-Zhi Chen; Susovan Mohapatra; Kamalika Mukherjee; Pallab Pradhan; Gnana Oli Rajaraman; Arkadeep Sinha; Christopher C. Stebbins; An Zhao; Zhandong Don Zhong; Robert J. Kubiak展开收起
作者单位
1. Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, Gothenborg, Sweden; 2. Boehringer Ingelheim Pharmaceuticals, Ridgefield, USA; 3. Stoke Therapeutics, Boston, USA; 4. Regeneron Pharmaceuticals, Tarrytown, USA; 5. AstraZeneca, Gaithersburg, USA; 6. AiCuris Anti-Infective Cures AG, Wuppertal, Germany; 7. Upstream Bio, Waltham, USA; 8. Immunologix Laboratories, Tampa, USA; 9. Denali Therapeutics, South San Francisco, USA; 10. Third Arc Bio, Lower Gwynedd, USA展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。